D.E. Shaw & Co
ARIA

D.E. Shaw & Co’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

D.E. Shaw & Co’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-227,600
Closed -$1.83M – 4767
2014
Q1 		$1.83M Buy
+227,600
New +$1.77M ﹤0.01% 2478

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

D.E. Shaw & Co's ARIA Position: Q1 2017 in Review

D.E. Shaw & Co sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 65,062 shares — an estimated $809K sold.

D.E. Shaw & Co first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $7.33M in Q4 2015. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • D.E. Shaw & Co reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • D.E. Shaw & Co sold 65,062 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $809K.
  • D.E. Shaw & Co first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • D.E. Shaw & Co's Ariad Pharmaceuticals Inc position peaked at $7.33M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on D.E. Shaw & Co's 13F filing for Q1 2017, filed 15 May 2017.